CD5 and B-cell chronic lymphocytic leukemia: As transitional B-cells were excluded from molecular studies addressing the CLL B-cell normal counterpart (11–13, 32), it would be interesting to compare the gene expression, miRNA, and epigenetic profile of transitional B-cell subsets (at least the CD5+ subset) with that of CLL B-cells.